Is Novo Nordisk A/S stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
Yes, Novo Nordisk A/S pays dividends. Last time was Thursday 1st of January 1970 where the investors holding the stock on Friday 18th of August 2023 were paid €6 per share. Over the last 30 times between 2002 and 2023, Novo Nordisk A/S has paid €343.8 with an average of €11.46 per share.
Sorry, we do not have any analyst data for this ticker
We cannot find data for Novo Nordisk A/S 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was €22.99, you would have made a profit of €68.41 per share or 297.56%
Yes, the average daily trading liquidity for Novo Nordisk A/S is €51 037 thousand. You should therefore be able to get in and out of your positions relatively fast.
Novo Nordisk A/S has little of the business financed by loans. This puts the company at lower risk in periods of high inflation where borrowing costs usually go up. With a high cash flow to debt ratio of 4.01, the company's ability to pay off the debt is good. Novo Nordisk A/S has a very good net profit margin of 35.11% and should have very high tolerances against inflation.
We have calculated the inflation risk for Novo Nordisk A/S to be low [0 of 1]
US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.